PTEN/PTENP1:'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy

N Haddadi, Y Lin, G Travis, AM Simpson, NT Nassif… - Molecular cancer, 2018 - Springer
Regulation of the PI-3 kinase (PI3K)/Akt signalling pathway is essential for maintaining the
integrity of fundamental cellular processes, cell growth, survival, death and metabolism, and …

[PDF][PDF] The PI3K/AKT pathway in the pathogenesis of prostate cancer

H Chen, L Zhou, X Wu, R Li, J Wen… - … Biosci (Landmark Ed), 2016 - article.imrpress.com
Despite recent advances in our understanding of the biological behavior of prostate cancer
(PCa), PCa is becoming the most common malignancy in men worldwide. The …

[HTML][HTML] Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

AT Parsa, JS Waldron, A Panner, CA Crane… - Nature medicine, 2007 - nature.com
Cancer immunoresistance and immune escape,, may play important roles in tumor
progression and pose obstacles for immunotherapy. Expression of the immunosuppressive …

Principles of tumor suppression

CJ Sherr - Cell, 2004 - cell.com
Molecular genetic studies of familial cancer syndromes identified and defined the recessive
nature of tumor suppressor genes and resolved the paradox of why tumors arising in such …

[HTML][HTML] Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia

T Palomero, ML Sulis, M Cortina, PJ Real, K Barnes… - Nature medicine, 2007 - nature.com
Gain-of-function mutations in NOTCH1 are common in T-cell lymphoblastic leukemias and
lymphomas (T-ALL), making this receptor a promising target for drugs such as γ-secretase …

The Identification of 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a Potent, Selective …

AJ Folkes, K Ahmadi, WK Alderton, S Alix… - Journal of medicinal …, 2008 - ACS Publications
Phosphatidylinositol-3-kinase (PI3K) is an important target in cancer due to the deregulation
of the PI3K/Akt signaling pathway in a wide variety of tumors. A series of thieno [3, 2-d] …

[HTML][HTML] The two TORCs and AKT

PT Bhaskar, N Hay - Developmental cell, 2007 - cell.com
The regulatory circuits that control the activities of the two distinct target of rapamycin (TOR)
complexes, TORC1 and TORC2, and of Akt have been a focus of intense research in recent …

[HTML][HTML] Protein-tyrosine phosphatases and cancer

A Östman, C Hellberg, FD Böhmer - Nature Reviews Cancer, 2006 - nature.com
Tyrosine phosphorylation is an important signalling mechanism in eukaryotic cells. In
cancer, oncogenic activation of tyrosine kinases is a common feature, and novel anticancer …

[HTML][HTML] Chemotaxis: signalling the way forward

PJM Van Haastert, PN Devreotes - Nature reviews Molecular cell …, 2004 - nature.com
During random locomotion, human neutrophils and Dictyostelium discoideum amoebae
repeatedly extend and retract cytoplasmic processes. During directed cell migration …

A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes

OA Kent, JT Mendell - Oncogene, 2006 - nature.com
The known classes of genes that function as tumor suppressors and oncogenes have
recently been expanded to include the microRNA (miRNA) family of regulatory molecules …